Defective Lipoprotein Receptors and Atherosclerosis
Franklin H. Epstein, Joseph L. Goldstein, Toru Kita et al. · New England Journal of Medicine · 1983
In 1913, Anitschkow fed cholesterol to rabbits, and thereby demonstrated that a high blood level of cholesterol can produce atherosclerosis in animals just as it can in human beings — with one fundamental difference. Human hypercholesterolemia is caused by genetic or acquired abnormalities in the synthesis or degradation of plasma lipoproteins that shuttle endogenous cholesterol between body tissues; dietary cholesterol is only an indirect aggravating factor. In laboratory animals hypercholesterolemia is produced exogenously when the normal mechanisms of lipoprotein clearance are overwhelmed by large amounts of dietary cholesterol. Since dietary and endogenous cholesterol are transported by different plasma lipoproteins, the . . .
Cited by 469 works. doi:10.1056/nejm198308043090507
Authors
References
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observations
- The Pathogenesis of Atherosclerosis
- Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Activity in Cultured Human Fibroblasts
- LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
- Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
- Regulation of Plasma Cholesterol by Lipoprotein Receptors
- Lipoprotein receptors and cholesterol homeostasis
- Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight.
- Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
- Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.